Exosens (LON: 0EXO)
London
· Delayed Price · Currency is GBP · Price in EUR
21.02
+0.28 (1.37%)
At close: Jan 22, 2025
Exosens Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue | 353.72 | 291.82 | 200.75 | 166.17 | 149.86 |
Revenue Growth (YoY) | - | 45.36% | 20.81% | 10.88% | - |
Cost of Revenue | 151.72 | 126.82 | 84.46 | 64.57 | 56.97 |
Gross Profit | 202 | 165 | 116.29 | 101.6 | 92.89 |
Selling, General & Admin | 101.11 | 84.51 | 64.63 | 57.74 | 53.23 |
Other Operating Expenses | 32.75 | 27.85 | 21.58 | 14.38 | 9.61 |
Operating Expenses | 137.86 | 112.36 | 86.2 | 72.12 | 62.85 |
Operating Income | 64.14 | 52.64 | 30.09 | 29.48 | 30.05 |
Interest Expense | -43.11 | -26.91 | -15.15 | -37.6 | -41.88 |
Earnings From Equity Investments | - | - | - | - | 0.04 |
Currency Exchange Gain (Loss) | -2.68 | -2.68 | 1.57 | 4.38 | -3.66 |
Other Non Operating Income (Expenses) | 1.54 | 1.54 | 2.93 | -2.66 | 2.22 |
EBT Excluding Unusual Items | 19.9 | 24.6 | 19.43 | -6.4 | -13.24 |
Merger & Restructuring Charges | -4.36 | -4.36 | -2.32 | - | - |
Impairment of Goodwill | - | - | - | -143.87 | - |
Pretax Income | 15.54 | 20.24 | 17.11 | -150.26 | -13.24 |
Income Tax Expense | 2.53 | 1.83 | 5.89 | -1.3 | 2.59 |
Net Income | 13.01 | 18.41 | 11.21 | -148.97 | -15.83 |
Preferred Dividends & Other Adjustments | 11.05 | 11.05 | 10.41 | - | - |
Net Income to Common | 1.95 | 7.35 | 0.8 | -148.97 | -15.83 |
Net Income Growth | - | 64.16% | - | - | - |
Shares Outstanding (Basic) | - | 76 | 76 | 76 | - |
Shares Outstanding (Diluted) | - | 76 | 76 | 76 | - |
EPS (Basic) | - | 0.10 | 0.01 | -1.96 | - |
EPS (Diluted) | - | 0.10 | 0.01 | -1.96 | - |
EPS Growth | - | 868.03% | - | - | - |
Free Cash Flow | 43.43 | 19.53 | 25.69 | 23.07 | 30.35 |
Free Cash Flow Per Share | - | 0.26 | 0.34 | 0.30 | - |
Gross Margin | 57.11% | 56.54% | 57.93% | 61.14% | 61.99% |
Operating Margin | 18.13% | 18.04% | 14.99% | 17.74% | 20.05% |
Profit Margin | 0.55% | 2.52% | 0.40% | -89.65% | -10.56% |
Free Cash Flow Margin | 12.28% | 6.69% | 12.79% | 13.88% | 20.25% |
EBITDA | 87.44 | 71.94 | 43.56 | 34.99 | 34.87 |
EBITDA Margin | 24.72% | 24.65% | 21.70% | 21.05% | 23.27% |
D&A For EBITDA | 23.29 | 19.29 | 13.47 | 5.5 | 4.83 |
EBIT | 64.14 | 52.64 | 30.09 | 29.48 | 30.05 |
EBIT Margin | 18.13% | 18.04% | 14.99% | 17.74% | 20.05% |
Effective Tax Rate | 16.30% | 9.06% | 34.45% | - | - |
Advertising Expenses | - | 1.65 | 1.47 | 0.76 | 0.31 |
Source: S&P Capital IQ. Standard template. Financial Sources.